Results 231 to 240 of about 171,627 (282)
In ovarian cancer, MEOX1 activates the SPHK1/S1P pathway to promote both tumor progression and tumor–stroma crosstalk. MEOX1‐dependent signaling drives CAF activation, enhances VEGF‐C expression, and stimulates lymphangiogenesis, ultimately facilitating lymph node metastasis.
Jiajia Li +10 more
wiley +1 more source
Platelet dense granule defect: experience in the French population. [PDF]
Borgel D +19 more
europepmc +1 more source
Hemostasis in Liver Disease Within Patient Blood Management: A Scoping Review of the Current Literature. [PDF]
Czempik PF +3 more
europepmc +1 more source
Neonatal Sepsis-Induced Coagulopathy in the Light of Developmental Hemostasis: Friend or Foe? [PDF]
Papadogeorgou P +6 more
europepmc +1 more source
Persistent thrombocytosis in β-thalassemia post-splenectomy: A STROBE-compliant retrospective cohort study at a Jordanian referral center. [PDF]
Alesufi A +9 more
europepmc +1 more source
Total Thrombus-Formation Analysis System (T-TAS) in Aortopathies: A Conceptual and Potential Framework to Spatial Heterogeneity and Regional Context. [PDF]
Krych S +6 more
europepmc +1 more source
The fluid challenge: Evaluating supportive care in dengue through radiological and clinical markers. [PDF]
Singh P, Bajaj N, Namdev J, Singh R.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet, 1969
The following platelet function tests are discussed: bleeding time, platelet retention tests, platelet aggregation, and radio-immunoassays for platelet release products, such as β thromboglobulin (βTG), and platelet factor 4 (PF4).
J W, ten Cate, S I, de Vries
+5 more sources
The following platelet function tests are discussed: bleeding time, platelet retention tests, platelet aggregation, and radio-immunoassays for platelet release products, such as β thromboglobulin (βTG), and platelet factor 4 (PF4).
J W, ten Cate, S I, de Vries
+5 more sources

